testosterone undecanoate: Clinical Trials

16 trials of testosterone undecanoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 terminated, 1 recruiting, 1 unknown. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 11, Terminated 2, Recruiting 1, Unknown 1, Withdrawn 1

Follow testosterone undecanoate: new trials by email Literature Review of testosterone undecanoate trials Research Report on testosterone undecanoate

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
Testosterone Undecanoate, Placebo - Fatty Liver, Overweight/Obesity
Phase 4RecruitingAlexandra Kautzky-Willer322022-01-252024-03-13
Testosterone in Bariatric Patients
Testosterone Undecanoate - Bariatric Surgery Candidate, Male Hypogonadism
Phase 4CompletedEsbjerg Hospital - University Hospital of Southern Denmark642020-12-172026-09-11
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male
Phase 4CompletedEndo USA Inc., a Keenova Therapeutics Company6732020-06-302025-03-14
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
Testosterone Undecanoate, Sesame Oil - Caloric Restriction, Exercise
Phase 4CompletedPennington Biomedical Research Center342019-09-232022-10-07
Effects of Testosterone on Myocardial Repolarization
Testosterone Undecanoate - Hypogonadism, Chronic Heart Failure
Phase 4CompletedUniversity of Roma La Sapienza1232016-09-012017-05-08
Testosterone Therapy in Hypogonadal Men Treated With Opioids
Testosterone, placebo - Hypogonadism
Phase 4CompletedMarianne Andersen402015-05-012020-09-16
Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)
Testosterone Undecanoate, Placebo - Hypogonadism, Male, Diabetes Mellitus, Type 2
Phase 4CompletedUniversity Medical Centre Ljubljana552014-01-102019-01-04
Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Testosterone - Type 2 Diabetes, Hypogonadism
Phase 4TerminatedTameside Hospital NHS Foundation Trust222013-10-112019-04-04
Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects
Testosterone undecanoate, Saline isotonic solution - Heart Failure
Phase 4CompletedFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia142011-03-012017-12-13
NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
Testosterone Undeconate (Nebido, BAY86-5037), Placebo - Hypogonadism
Phase 4TerminatedBayer42010-09-012014-11-05
Sex Steroids and the Serotonin Transporter
Testolactone undecanoate, Lynestrenol, Cyproterone Acetate - Transsexualism
Phase 4CompletedMedical University of Vienna322010-02-012014-01-03
Exercise Training and Testosterone Replacement in Heart Failure Patients
Testosterone replacement, Exercise training - Heart Failure
Phase 4CompletedUniversity of Sao Paulo General Hospital392009-07-012016-12-15
Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks
NEBIDO, PLACEBO - Hypogonadism
Phase 4WithdrawnBayer2008-10-012012-11-27
Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate
Testosterone Undecanoate and/or PDE-5 - Erectile Dysfunction, Hypogonadotrophic Males
Phase 4UnknownHospital Santa Fe502007-05-012007-11-07
The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
Testosterone Undecanoate,1000mg - Hypogonadism, Erectile Dysfunction
Phase 4CompletedChulalongkorn University302007-01-012012-05-15
Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina
Nebido - Angina Pectoris
Phase 4CompletedSheffield Teaching Hospitals NHS Foundation Trust152005-09-012019-10-02

Conditions studied

Hypogonadism (8)  ·  Eunuchism (4)  ·  Diabetes Mellitus, Type 2 (2)  ·  Erectile Dysfunction (2)  ·  Heart Failure (2)  ·  Obesity (2)  ·  Angina Pectoris (1)  ·  Arteriosclerosis (1)  ·  Diabetes Mellitus (1)  ·  Fatty Liver (1)  ·  Gender Dysphoria (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Motor Activity (1)  ·  Muscular Atrophy (1)

Sponsors

Bayer (2)  ·  Alexandra Kautzky-Willer (1)  ·  Chulalongkorn University (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Esbjerg Hospital - University Hospital of Southern Denmark (1)  ·  Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (1)  ·  Hospital Santa Fe (1)  ·  Marianne Andersen (1)  ·  Medical University of Vienna (1)  ·  Pennington Biomedical Research Center (1)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)  ·  Tameside Hospital NHS Foundation Trust (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Roma La Sapienza (1)  ·  University of Sao Paulo General Hospital (1)

Countries

United Kingdom (3)  ·  Austria (2)  ·  Denmark (2)  ·  Germany (2)  ·  United States (2)  ·  Brazil (1)  ·  Italy (1)  ·  Latvia (1)  ·  Mexico (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

Alexandra Kautzky-Willer, MD (1)  ·  Antoni Bayes-Genis, MD, PhD (1)  ·  Apichat Kongkanand, Professor (1)  ·  David Hernandez (1)  ·  Domingo A Pascual-Figal, MD, PhD (1)  ·  Edward Jude, MD, MRCP (1)  ·  Jennifer C Rood, PhD (1)  ·  Jorge Jaspersen, MD (1)  ·  Kevin S Channer, MBChB (Hons) (1)  ·  Kristina Groti Antonic, MD, PhD (1)  ·  Line V Magnussen, MD, PhD (1)  ·  Maria Janieire N Alves, MD; PhD (1)  ·  Rupert Lanzenberger, MD A/Prof (1)

Results publications

PMID 25497691, PMID 29929385, PMID 34278044, PMID 36796647, PMID 36949577, PMID 38088425, PMID 40279652

NIH funding

2009 (2), 2008 (1), 2017 (1), 2018 (1)